Adela
Foster City
About Adela
Adela develops innovative and accessible technologies focusing on the detection of cancer and other high-morbidity, high-mortality conditions through a routine blood test. Adela’s genome-wide methylome enrichment platform captures information efficiently from the entire methylome. Its technology distinguishes the most-highly informative (methylated) regions of the genome from non-informative regions and preferentially targets those regions for sequencing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $108.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2023)
- Website: adelabio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/adela-71196 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.